BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 17684365)

  • 21. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Fan JH; Qian JB; Wang YM; Shi RH; Zhao CJ
    World J Gastroenterol; 2015 Jun; 21(24):7577-83. PubMed ID: 26140006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical prevention of post-ERCP pancreatitis by pancreatic stents: results, techniques, and indications.
    Tarnasky PR
    JOP; 2003 Jan; 4(1):58-67. PubMed ID: 12555017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials.
    Cennamo V; Fuccio L; Zagari RM; Eusebi LH; Ceroni L; Laterza L; Fabbri C; Bazzoli F
    Endoscopy; 2010 May; 42(5):381-8. PubMed ID: 20306386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin for post-ERCP pancreatitis prophylaxis: another attempt at the Holy Grail.
    Wagh MS; Sherman S
    Am J Gastroenterol; 2007 May; 102(5):984-6. PubMed ID: 17489783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
    Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
    Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
    Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA;
    Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapy for the prevention of post-ERCP pancreatitis.
    Foster E; Leung J
    Am J Gastroenterol; 2007 Jan; 102(1):52-5. PubMed ID: 17266688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does endoscopic sphincterotomy reduce the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis after biliary stenting? A systematic review and meta-analysis.
    Sofi AA; Nawras A; Alaradi OH; Alastal Y; Khan MA; Lee WM
    Dig Endosc; 2016 May; 28(4):394-404. PubMed ID: 26636754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
    Choi CW; Kang DH; Kim GH; Eum JS; Lee SM; Song GA; Kim DU; Kim ID; Cho M
    Gastrointest Endosc; 2009 Apr; 69(4):e11-8. PubMed ID: 19327467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic approach to acute pancreatitis.
    Kinney TP; Lai R; Freeman ML
    Rev Gastroenterol Disord; 2006; 6(3):119-35. PubMed ID: 16957653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis.
    Bailey AA; Bourke MJ; Williams SJ; Walsh PR; Murray MA; Lee EY; Kwan V; Lynch PM
    Endoscopy; 2008 Apr; 40(4):296-301. PubMed ID: 18389448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
    Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
    J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early endoscopic retrograde cholangiopancreatography in predicted severe acute biliary pancreatitis: a prospective multicenter study.
    van Santvoort HC; Besselink MG; de Vries AC; Boermeester MA; Fischer K; Bollen TL; Cirkel GA; Schaapherder AF; Nieuwenhuijs VB; van Goor H; Dejong CH; van Eijck CH; Witteman BJ; Weusten BL; van Laarhoven CJ; Wahab PJ; Tan AC; Schwartz MP; van der Harst E; Cuesta MA; Siersema PD; Gooszen HG; van Erpecum KJ;
    Ann Surg; 2009 Jul; 250(1):68-75. PubMed ID: 19561460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.